IL151696A0 - Polysaccharidic esters of n-derivatives of glutamic acid - Google Patents

Polysaccharidic esters of n-derivatives of glutamic acid

Info

Publication number
IL151696A0
IL151696A0 IL15169601A IL15169601A IL151696A0 IL 151696 A0 IL151696 A0 IL 151696A0 IL 15169601 A IL15169601 A IL 15169601A IL 15169601 A IL15169601 A IL 15169601A IL 151696 A0 IL151696 A0 IL 151696A0
Authority
IL
Israel
Prior art keywords
derivatives
esters
glutamic acid
polysaccharidic
polysaccharidic esters
Prior art date
Application number
IL15169601A
Other languages
English (en)
Original Assignee
Eurand Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand Pharmaceuticals Ltd filed Critical Eurand Pharmaceuticals Ltd
Publication of IL151696A0 publication Critical patent/IL151696A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
IL15169601A 2000-03-17 2001-03-16 Polysaccharidic esters of n-derivatives of glutamic acid IL151696A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI000559A IT1318403B1 (it) 2000-03-17 2000-03-17 Esteri polisaccaridici di n-derivati di acido glutammico.
PCT/EP2001/003050 WO2001068105A1 (en) 2000-03-17 2001-03-16 Polysaccharidic esters of n-derivatives of glutamic acid

Publications (1)

Publication Number Publication Date
IL151696A0 true IL151696A0 (en) 2003-04-10

Family

ID=11444509

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15169601A IL151696A0 (en) 2000-03-17 2001-03-16 Polysaccharidic esters of n-derivatives of glutamic acid

Country Status (16)

Country Link
US (2) US6844328B2 (zh)
EP (1) EP1274446B1 (zh)
JP (1) JP2003526720A (zh)
KR (1) KR20020093845A (zh)
CN (1) CN1203071C (zh)
AT (1) ATE304363T1 (zh)
AU (1) AU784655B2 (zh)
BR (1) BR0109294A (zh)
CA (1) CA2403063A1 (zh)
DE (1) DE60113398T2 (zh)
ES (1) ES2248322T3 (zh)
IL (1) IL151696A0 (zh)
IT (1) IT1318403B1 (zh)
MX (1) MXPA02009057A (zh)
WO (1) WO2001068105A1 (zh)
ZA (1) ZA200208299B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318403B1 (it) * 2000-03-17 2003-08-25 Cooperativa Ct Ricerche Poly T Esteri polisaccaridici di n-derivati di acido glutammico.
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7906492B2 (en) 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
ITTS20010016A1 (it) * 2001-06-20 2002-12-20 Ct Ricerche Poly Tec H A R L S Polisaccaridi regioselettivamente reticolati.
JP4524078B2 (ja) * 2002-05-31 2010-08-11 富士フイルム株式会社 磁性粒子およびその製造方法、並びに、磁気記録媒体およびその製造方法
AU2005219733C1 (en) 2004-03-05 2010-12-16 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid-methotrexate conjugate
US7807675B2 (en) * 2004-04-02 2010-10-05 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid-methotrexate conjugate
CN101227906A (zh) * 2005-05-18 2008-07-23 欧兰德制药有限公司 包含透明质酸和谷氨酸的n-衍生物的抗增生共轭物
CN100391585C (zh) * 2005-08-08 2008-06-04 武汉大学 二烷基谷氨酸糖酯表面活性剂及其制备方法和用途
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
IE20060049A1 (en) * 2006-01-25 2007-08-08 Eurand Pharmaceuticals Ltd A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents
IE20060565A1 (en) * 2006-07-28 2008-02-06 Eurand Pharmaceuticals Ltd Drug delivery system based on regioselectively amidated hyaluronic acid
ITMI20072416A1 (it) * 2007-12-21 2009-06-22 Sigea Srl Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
CN102337296A (zh) * 2011-07-05 2012-02-01 天津大学 葡聚糖—胍基丁胺聚阳离子转基因载体及其制备方法和应用
KR101467076B1 (ko) * 2013-02-20 2014-12-02 성균관대학교산학협력단 히알루론산-메토트렉세이트 접합체를 포함하는 관절염 예방 또는 치료용 약학적 조성물 및 이의 제조방법
CN106459029B (zh) 2014-06-26 2019-10-25 豪夫迈·罗氏有限公司 二氢吲哚-2-酮或吡咯并-吡啶-2-酮衍生物
CR20180255A (es) 2015-11-06 2018-06-22 Hoffmann La Roche Derivados de indolin-2-ona
JP6857653B2 (ja) 2015-11-06 2021-04-14 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｃｎｓ及び関連障害の治療において使用するためのインドリン−２−オン誘導体

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8762982A (en) * 1981-07-02 1983-02-02 Walton, A.G. Glycosaminoglycan drug complexes
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
DD267497A1 (de) * 1987-11-11 1989-05-03 Akad Wissenschaften Ddr Verfahren zur bindung von methotrexat an polysaccharide
DE3904119A1 (de) 1989-02-11 1990-08-16 Hoechst Ag Polymerfixiertes methotrexat, verfahren zur herstellung und verwendung
US5733891A (en) 1990-10-18 1998-03-31 Shiseido Co., Ltd. Compound for medicinal ingredient and hyaluronic acid and process for producing the same
US5698556A (en) * 1995-06-07 1997-12-16 Chan; Carcy L. Methotrexate analogs and methods of using same
IT1286510B1 (it) 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
CA2208924A1 (en) 1997-07-09 1999-01-09 Hyal Pharmaceutical Corporation Sparing paclitaxel by the use of hyaluronan
IT1295298B1 (it) 1997-10-08 1999-05-04 Cooperativa Centro Ricerche Po Polisaccaridi carbossilati 6-sostituiti
IT1318403B1 (it) * 2000-03-17 2003-08-25 Cooperativa Ct Ricerche Poly T Esteri polisaccaridici di n-derivati di acido glutammico.

Also Published As

Publication number Publication date
US20030158125A1 (en) 2003-08-21
WO2001068105A1 (en) 2001-09-20
ITMI20000559A1 (it) 2001-09-17
MXPA02009057A (es) 2004-09-06
KR20020093845A (ko) 2002-12-16
US20050065112A1 (en) 2005-03-24
JP2003526720A (ja) 2003-09-09
ITMI20000559A0 (it) 2000-03-17
ATE304363T1 (de) 2005-09-15
US6844328B2 (en) 2005-01-18
ES2248322T3 (es) 2006-03-16
BR0109294A (pt) 2002-12-17
CN1418103A (zh) 2003-05-14
AU5828601A (en) 2001-09-24
ZA200208299B (en) 2003-12-15
IT1318403B1 (it) 2003-08-25
DE60113398T2 (de) 2006-06-29
DE60113398D1 (de) 2005-10-20
CA2403063A1 (en) 2001-09-20
AU784655B2 (en) 2006-05-18
CN1203071C (zh) 2005-05-25
EP1274446A1 (en) 2003-01-15
EP1274446B1 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
IL151696A0 (en) Polysaccharidic esters of n-derivatives of glutamic acid
EP1404360A4 (en) MIXTURES OF CALCITONIN AND OLIGOMER-BASED DRUG CONJUGATES COMPRISING POLYALKYLENE GLYCOL, AND USES AND METHODS OF PREPARING THE SAME
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
MA26769A1 (fr) Derives de thioamide.
PL350453A1 (en) N−cyanomethyl amides as protease inhibitors
MXPA03011284A (es) Mezclas de conjugados de farmaco de insulina-oligomero que comprenden polialquilenglicol, usos de los mismos y metodos para eleaborar los mismos.
ES2192213T3 (es) Arilalquil-diazinonas como inhibidores de fosfodiesterasa iv.
BR0116464A (pt) imidazoquinolinas substituìdas com amido éter
FI20011851A (fi) Fluoksetiinia tai sen happoadditiosuolaa sisältävä dispergoituva tabletti
ATE232396T1 (de) Oxydiertes thymosin beta 4
DE69410121T2 (de) Dihydro pyrazolopyrrole
GEP20053616B (en) Polysaccharides with Antithrombotic Activity Comprising At Least one Covalent Bond with Biotin or Biotin Derivative
NO980313L (no) N-(aroyl)glysin-hydroksaminsyre-derivater og beslektete forbindelser
DK0939627T3 (da) Pentaflourbenzensulfonamider og analoger
MY109722A (en) Azaoxindole derivatives.
AR034343A1 (es) Combinaciones farmaceuticas
PT1017404E (pt) Formulacao farmaceutica para o tratamento de doenca inflamatoria do intestino
GR3034575T3 (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
AU6682594A (en) Treatment of septic shock
SE9700934D0 (sv) New formulation
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
DE60027905D1 (de) Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung
EA199700243A1 (ru) Производное аминотетралина для лечения сердечно-сосудистых заболеваний